Dossier
B. Ekbal
Coverage of B. Ekbal in the Nexus archive.
- Spinal Muscular Atrophy drug: regulatory approval should guide Kerala’s procurement policy, say experts
Experts argue that Kerala should prioritize procuring a regulatory-approved generic formulation of the Spinal Muscular Atrophy drug over the original molecule, which is significantly more expensive. B. Ekbal highlights the cost disparity, stating the generic version is available at a fraction of the price.
- MCH incident sparks call for urgent clinical, medical audit of patient care procedures
The MCH incident has prompted calls for an urgent clinical and medical audit of patient care procedures. Public health expert B. Ekbal highlights systemic failures in healthcare systems rather than individual negligence, urging the Health department to establish robust monitoring protocols to ensure patient safety.